Selective inhibition of bacterial topoisomerase I by alkynyl-bisbenzimidazoles

3,4-Dimethoxyphenyl bis-benzimidazole, a novel DNA topoisomerase inhibitor that preferentially targets Escherichia coli topoisomerase I

(2012) S. Bansal et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Triple Recognition of B-DNA by a Neomycin−Hoechst 33258−Pyrene Conjugate

(2009) Bert Willis et al.   BIOCHEMISTRY

Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents

(2009) Laixing Hu et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents

(2009) Laixing Hu et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition

(2009) Yves Pommier   CHEMICAL REVIEWS

Old class but new dimethoxy analogue of benzimidazole: a bacterial topoisomerase I inhibitor

(2009) Sandhya Bansal et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazoles as antimicrobial and antituberculosis agents

(2008) Ganesh Rajaram Jadhav et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Bacterial topoisomerase I as a target for discovery of antibacterial compounds

(2008) Y.-C. Tse-Dinh   NUCLEIC ACIDS RESEARCH